INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | -98.5% | 1,615 | -98.1% | 0.00% | -100.0% |
| Q2 2023 | $3,448 | +10.4% | 84,542 | +0.9% | 0.01% | +14.3% |
| Q1 2023 | $3,123 | -4.4% | 83,811 | -10.5% | 0.01% | -12.5% |
| Q4 2022 | $3,268 | -99.9% | 93,690 | +48.5% | 0.01% | -27.3% |
| Q3 2022 | $3,531,000 | -19.7% | 63,101 | -25.7% | 0.01% | -8.3% |
| Q2 2022 | $4,397,000 | -22.7% | 84,956 | +8.6% | 0.01% | 0.0% |
| Q1 2022 | $5,685,000 | -39.8% | 78,228 | -2.1% | 0.01% | -45.5% |
| Q4 2021 | $9,445,000 | +5.3% | 79,884 | +19.5% | 0.02% | -4.3% |
| Q3 2021 | $8,971,000 | – | 66,874 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |